Literature DB >> 11036004

Anti-human immunodeficiency virus activities of nucleosides and nucleotides: correlation with molecular electrostatic potential data.

T Mickle1, V Nair.   

Abstract

Examination of the anti-human immunodeficiency virus (HIV) data of some normal and isomeric dideoxynucleosides (ddNs and isoddNs), their three-dimensional (3-D) electron density patterns, their electrostatic potential surfaces (EPS), and their conformational maps reveals some interesting correlations. For example, the EPS of (S,S)-isoddA shows regions of high and low electrostatic potential remarkably similar to those of beta-D-3'-azido-3'-deoxythymidine (beta-D-AZT), (-)-oxetanocin A, and (-)-carbovir. Such correlations involving EPS data and anti-HIV activity were also found with many other active nucleosides. Conversely, inactive compounds had EPS different from those of compounds in the same series that were active. For example, apio-ddNs, which are inactive against HIV, exhibit clear differences in electrostatic potential and 3-D electron density shape from isoddNs that are active against HIV. Additionally, the inactivity of (S,S)-isoddC and (S,S)-isoddT can be correlated convincingly with a combination of their EPS data and their conformational energy maps. The electrostatic potential distributions of active nucleoside triphosphates show remarkable correlations. For example, (S,S)-isoddATP, AZT triphosphate (AZTTP), and oxetanocin A TP have similar 3-D electron density surface patterns and similar high and low regions of electrostatic potential, which may suggest that these compounds proceed through related mechanisms in their interactions with, and inhibition of, HIV reverse transcriptase (RT). Docking of AZTTP, (S,S)-isoddATP, and other active triphosphates into the active site of HIV RT and calculation of the EPS of both the nucleotide and the active site show that there is excellent matching between inhibitor and enzyme binding site EPS data. The structure-activity profile discovered has contributed to the development of a first predictive quantitative structure-activity relationship analysis in the area.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036004      PMCID: PMC101584          DOI: 10.1128/AAC.44.11.2939-2947.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV).

Authors:  T S Lin; J Y Guo; R F Schinazi; C K Chu; J N Xiang; W H Prusoff
Journal:  J Med Chem       Date:  1988-02       Impact factor: 7.446

2.  Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

Authors:  C K Chu; R F Schinazi; B H Arnold; D L Cannon; B Doboszewski; V B Bhadti; Z P Gu
Journal:  Biochem Pharmacol       Date:  1988-10-01       Impact factor: 5.858

3.  Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation.

Authors:  C Altona; M Sundaralingam
Journal:  J Am Chem Soc       Date:  1972-11-15       Impact factor: 15.419

4.  Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

Authors:  C K Chu; R F Schinazi; M K Ahn; G V Ullas; Z P Gu
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

5.  Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues.

Authors:  C H Kim; V E Marquez; S Broder; H Mitsuya; J S Driscoll
Journal:  J Med Chem       Date:  1987-05       Impact factor: 7.446

6.  Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.

Authors:  J Balzarini; M Baba; R Pauwels; P Herdewijn; E De Clerq
Journal:  Biochem Pharmacol       Date:  1988-07-15       Impact factor: 5.858

7.  Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro.

Authors:  R Vince; M Hua; J Brownell; S Daluge; F C Lee; W M Shannon; G C Lavelle; J Qualls; O S Weislow; R Kiser
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

8.  Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.

Authors:  P Herdewijn; J Balzarini; M Baba; R Pauwels; A Van Aerschot; G Janssen; E De Clercq
Journal:  J Med Chem       Date:  1988-10       Impact factor: 7.446

9.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

10.  3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.

Authors:  P Herdewijn; J Balzarini; E De Clercq; R Pauwels; M Baba; S Broder; H Vanderhaeghe
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.